Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2022

Open Access 01.12.2022 | Research

Continuous field flooding versus final one-shot CO2 insufflation in minimally invasive mitral valve repair

verfasst von: Giuseppe Nasso, Ignazio Condello, Giuseppe Santarpino, Nicola Di Bari, Marco Moscarelli, Felice Eugenio Agrò, Roberto Lorusso, Giuseppe Speziale

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2022

Abstract

Background

Insufflation of carbon dioxide (CO2) into the operative field to prevent cerebral or myocardial damage by air embolism is a well known strategy in open-heart surgery. However, here is no general consensus on the best delivery approach.

Methods

From January 2018 to November 2021, we retrospectively collected data of one hundred consecutive patients undergoing minimally invasive mitral valve repair (MIMVR). Of these, fifty patients were insufflated with continuous CO2 1 min before opening the left atrium and ended after its closure, and fifty patients were insufflated with one shot CO2 10 min before the start of left atrium closure. The primary outcome of the study was the incidence of transient post-operative cognitive disorder, in particular agitation and delirium at discontinuation of anesthesia, mechanical ventilation (MV) duration and intensive care unit (ICU) length of stay.

Results

In all patients that received continuous field flooding CO2, correction of ventilation for hypercapnia during cardiopulmonary bypass (CPB) was applied with an increase of mean sweep gas air (2.5 L) and monitoring of VCO2 changes. One patient vs. 9 patients of control group reported agitation at discontinuation of anesthesia (p = 0.022). MV duration was 14 ± 3 h vs. 27 ± 4 h (p = 0.016) and ICU length of stay was 33 ± 4 h vs. 42 ± 5 h (p = 0.029). A significant difference was found in the median number of total micro-emboli recorded from release of cross-clamp until 20 min after end of CPB (154 in the continuous CO2 group vs. 261 in the one-shot CO2 control group; p < 0.001). Total micro-emboli from the first 15 min after the release of cross-clamp was 113 in the continuous CO2 group vs. 310 in the control group (p < 0.001). In the continuous CO2 group, the median number of detectable micro-emboli after CPB fell to zero 9 ± 5 min after CPB vs. 19 ± 3 min in the control group (p = 0.85).

Conclusion

Continuous field flooding insufflation of CO2 in MIMVR is associated with a lower incidence of micro-emboli and of agitation at discontinuation of anesthesia, along with improved MV duration and ICU length of stay.
Hinweise
Giuseppe Nasso and Ignazio Condello contributed equally.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The presence of air micro-emboli in open-heart surgery correlates with the degree of post-operative neuropsychological disorder [1, 2]. Manual de-airing techniques have proved ineffective in eliminating air micro-emboli and even meticulous techniques are associated with the risk of a large number of micro-emboli [3, 4]. The neurological outcome is difficult to evaluate, due to possible bias such as the status and the age of the patient and symptoms (e.g. changes in personality) [5, 6].
However, it is possible that these changes are not connected with the operation itself but rather with the status of the patients, their age, sex, disease severity, or genetic factors [7, 8]. The use of carbon dioxide (CO2) in minimally invasive cardiac surgery is due to its high solubility and density in blood, allowing better tolerability of air embolism [9]. The use of endo-cavitary aspirators during mitral valve surgery contributes to capture in the extracorporeal circuit the quantity of CO2 continuously insufflated in the surgical field. This aspect is represented in the blood gas analysis and in the frequent correction of hypercapnia through ventilation in the oxygenator [10].
In this context we investigated the effect of CO2 on two groups of patients undergoing minimally invasive mitral valve repair (MIMVR) through a right mini-thoracotomy with two different CO2 delivery techniques (continuous vs. one end shot) and we compared the peri-operatory micro-embolic activity, the impact of CO2 in cardiopulmonary bypass (CPB) management, the incidence of transient post-operative cognitive disorder (TPOCD), mechanical ventilation (MV) duration and intensive care unit (ICU) length of stay.

Methods

Patient and data collection

A retrospective, observational study was undertaken of prospectively collected data in one hundred consecutive patients undergoing MIMVR from January 2018 to November 2021 at our Institution Anthea Hospital, GVM Care & Research, Bari, Italy. The median (interquartile range [IQR]) age was 66 (62–76) years, one hundred patients underwent MIMVR through a right thoracotomy approach. Patient characteristics are reported in Table 1. None of the study patients reported the use of psychiatric drugs, alcohol, and carotid artery stenosis prior to the procedure.
Table 1
Characteristics of the study population
 
All
(n = 100)
Continuous CO2
(n = 50)
One-shot CO2
(n = 50)
P-value
Age (years)
66 (62–76)
65 (62–78)
69 (67–79)
< 0.001
Male sex
52.5%
43.9%
38.7%
< 0.001
Body mass index (kg/m2)
25.8 (22.2–28.8)
26.8 (23.4–29.0)
24.3 (21.7–28.4)
0.191
Arterial hypertension
32.2%
33.3%
36.1%
0.789
Diabetes mellitus
    
Oral antidiabetic drugs
8.9%
7.2%
5.5%
0.006
Insulin
2.3%
2.8%
2.6%
0.530
Hypercholesterolemia
77.4%
38.1%
39.3%
0.899
Renal dysfunction*
1.4%
2.3%
2.1%
0.254
Respiratory or lung disease
2.1%
2.3%
1.9%
0.187
Previous disabling stroke
1.5%
1.5%
1.3%
0.687
History of cancer
1.4%
1.9%
2.5%
0.030
Atrial fibrillation
9.4%
8.3%
11.2%
< 0.001
Peripheral vascular disease
1.8%
1.6%
1.9%
0.556
Coronary artery disease
0.9%
0.8%
1.1%
0.81
LVEF
   
0.347
>50%
93.0%
92.0%
91.2%
 
30–50%
6.3%
7.5%
7.5%
 
<30%
0.7%
0.5%
1.3%
 
Previous surgery
2.3%
1.7%
1.9%
0.211
EuroSCORE II (%)
1.2 (1.1–2.8)
1.2 (1.1–2.7)
1.2 (1.1–2.8)
0.87
Values are given as median (interquartile range) or percentage
LVEF, left ventricular ejection fraction
*Dialysis or creatinine > 2 mg/dL
Fifty patients were insufflated with continuous CO2 1 min before opening the left atrium and ended after its closure, and fifty patients were insufflated with one shot CO2 10 min before the start of left atrium closure, at a continuous CO2 flow rate of 3 L/min via diffuser (Table 1). The main reason for performing two different methods of CO2 delivery during MIMVR was due to the different techniques used by cardiac surgeons for minimally invasive cardiac surgery. The aim and the methodology of the study was internal discussed with the ethics committee of the hospital according to the General Data Protection Regulation. Because of the retrospective nature of this study, the local ethics committees waived the need for patient consent. The transesophageal echocardiographic (TEE) protocol for the detection of micro-emboli requires to record intraoperative TEE from cross-clamping to 20 min after end of CPB.
Post-operatively, a blinded assessor determined the maximal number of gas emboli during each consecutive minute in the left atrium, left ventricle, and ascending aorta. The primary outcome of the study was the incidence of TPOCD (in particular agitation and delirium occurring 5 h following weaning from anesthesia), MV duration and ICU length of stay.
During the two procedures, correction for hypercapnia during CPB and monitoring of VCO2 changes were recoreded.

Surgical technique

Our surgical approach for minimally invasive direct view during mitral surgery was described elsewhere [11]. Arterial perfusion was always retrograde and peripheral and aortic cross-clamping was external in all patients. Venous cannulation was peripheral with vacuum support and a double site insertion of the cannulas (jugular and femoral). The valve inspection and procedure were through the left atrium with direct vision and the reconstruction technique was standardized [11].

CO2 insufflation management and CPB de-airing

A small PVC flexible drain tube was used for CO2 insufflation as per standardized procedure [12, 13] and flow measurement was performed with a flowmeter for medical CO2. The perfusionist regulates the flow according to pCO2 and pH. PaO2 during CPB was maintained between 150 and 250 mmHg, PaCO2 was maintained through the sweep gas (air flow from gas blender) between 40 and 45 mmHg with pH stat management, and mean arterial pressure was maintained between 50 and 70 mmHg [14, 15]. In both groups, the venting flow was maintained 800 ml/min after cross-clamping. Air embolism was managed under TEE guidance; the heart sections were filled, thus obstructing the venous return from CPB and increasing the cavity diameter, and the lungs were manually expanded using an Ambu® resuscitator (Ambu A/S,Ballerup, Denmark) at a rate of 4 inflations per minute. The ventricular and aortic intracavitary aspirators were managed at 750 ml/min and 800 ml/min after cross-clamp removal, and the aortic root vent was removed at the elimination of total gaseous micro-emboli.

Statistical analysis

Continuous data are expressed as median with IQR and categorical data as percentages. Cumulative survival was evaluated with the Kaplan–Meier method. All reported P-values are two-sided, and P-values of < 0.05 were considered to indicate statistical significance. All statistical analyses were performed with SPSS 22.0 (SPSS, Inc., Chicago, IL, USA).

Results

CPB duration was 78 ± 13 min and cross-clamp time was 40 ± 9 min (Table 2). The most predominant pathology was degenerative disease, followed by rheumatic mitral valve disease (Table 3). Mitral valve repair was performed in all patients with peripheral cannulation. Repair techniques included annuloplasty, leafleat resection, neochordae implantation and sliding plasty. Table 4 depicts the median number of micro-emboli during the first 15 min after release of the aortic cross-clamp in the three areas of interest taken together. All patients in both groups had micro-emboli after release of the aortic cross-clamp in all three areas of interest. The number of micro-emboli recorded with TEE was higher in the control group (Table 4) and remained constantly higher during all four time periods and in all three studied locations.
Table 2
Intraoperative data for surgical techniques and procedures
 
Continuous CO2
(n = 50)
One-shot CO2
(n = 50)
P-value
Cardiopulmonary bypass time (min)
79 (65–85)
74 (63–79)
0.98
Cross-clamp time (min)
41 (37–45)
43 (36–47)
0.89
Table 3
Mitral valve pathology for minimally invasive mitral valve repair
Mitral valve pathology
Right thoracotomy
(n = 100)
Continuous CO2
(n = 50)
One-shot CO2
(n = 50)
Degenerative
60 (60%)
26 (52%)
34 (68%)
Functional
28 (28%)
17 (34%)
11 (22%)
Rheumatic
12 (12%)
7 (14%)
5 (10%)
Table 4
Number of microemboli on transesophageal echocardiographic evaluation of the left atrium and ventricle and the proximal ascending aorta
Time period/area of interest
No. of microemboli
P-value
Continuous CO 2
(n = 50)
One-shot CO 2
(n = 50)
From release of cross-clamp until 20 min after end of CPB
   
LA
59 (43–79)
98 (39–129)
< 0.001
LV
49 (45–74)
87 (59–112)
< 0.001
Ao
42 (34–58)
76 (32–88)
< 0.001
LA + LV + Ao
154 (84–195)
261(146–299)
< 0.001
First 15 min after release of cross-clamp
   
LA
46 (38–96)
139 (99–159)
< 0.01
LV
65 (58–93)
96 (81–109)
< 0.001
Ao
25 (19–39)
75 (42–89)
< 0.001
LA + LV + Ao
113 (86–157)
310(290–343)
< 0.001
Last 10 min of CPB
   
LA
17 (11–43)
27 (9–41)
< 0.01
LV
19 (11–29)
48 (9–59)
< 0.001
Ao
16 (12–37)
36 (25–56)
< 0.01
LA + LV + Ao
52 (42–87)
141(122–156)
< 0.001
First 20 min after end of CPB
   
LA
8 (4–21)
48 (19–54)
< 0.01
LV
13 (5–25)
34 (15–41)
0.01
Ao
16 (8–28)
83 (68–98)
< 0.01
LA + LV + Ao
37 (27–58)
165(120–197)
< 0.01
Values are given as median (25th–75th percentile)
Ao, aorta; CPB, cardiopulmonary bypass; LA, left atrium; LV, left ventricle
In the continuous field flooding CO2 group, the median number of detectable micro-emboli after CPB fell to zero 9 ± 5 min after CPB versus 19 ± 3 min in the one-shot CO2 control group (p = 0.01). In patients of the continuous field flooding CO2 group, correction of ventilation for hypercapnia during CPB was applied, with an increase of mean sweep gas air (2.5 L) and monitoring of VCO2 changes. One patient of the continuous CO2 group vs. 9 patients of the control group reported agitation at discontinuation of anesthesia (p = 0.022). MV duration was 14 ± 3 h vs. 27 ± 4 h (p = 0.016) and ICU length of stay was 33 ± 4 h vs. 42 ± 5 h (p = 0.029) in the continuous CO2 vs. control group, respectively (Table 5). In the whole study population, no transient ischemic attack or stroke was reported at postoperative clinical evaluation (Fig. 1).
Table 5
Peri-operative and post-operative outcome
 
Continuous CO2
(n = 50)
One-shot CO2
(n = 50)
P-value
Microemboli after CPB fell to zero (min)
9 ± 5
19 ± 3
0.01
Agitation at anesthesia discontinuation (no. of patients)
1
9
0.022
Mechanical ventilation (h)
14 ± 3
27 ± 4
0.016
ICU length of stay (h)
33 ± 4
42 ± 5
0.029
CPB, cardiopulmonary bypass; ICU, intensive care unit

Discussion

Previous studies [16, 17] demonstrated that the patients without CO2 use had persistent air bubbles for many minutes after the end of CPB but these studies were not performed under TEE control, as in our analysis, and no cerebro-vascular outcome was reported [18, 19].
Moreover, subsequent randomized studies showed no difference or were too small to demonstrate a difference in neurocognitive outcome between CO2 and no-CO2 use [20, 21]. In other words, our study is the first that demonstrate a clinical impact of that strategy.
However, the centrality of TEE use has been previously highlighted for bubble observation [19] but not yet for the clinical outcome effect. Other authors, on the other hand, demonstrated an impact on cardiac function due to less air bubbles in the heart [22]. It should be noted that all these studies tried to compare the use vs. non-use of CO2. We are the first that tried to demonstrate a difference in the use of the CO2 strategy trying to reduce the possible site effects of CO2 (e.g. high pCO2) with the support of the perfusionist and a strategy that focuses the use of gas only during the phase of chamber opening. An excess of micro-embolic activity could influence the patient’s awakening by giving drowsiness and transient agitation, this would seem to have an indirect impact on the lack of collaboration by prolonging the time of MV and ICU length of stay.
The main limitation of our study is the quantitative assessment of gaseous micro-embolic activity with a correlation for the primary endpoint of the incidence of TPOCD (in particular agitation and delirium upon discontinuation of anesthesia), MV duration and ICU length of stay, which should be further explored in future studies with instrumental investigations (e.g. magnetic resonance imaging), and be correlated with intraoperative bispectral index, electroencephalogram, and evaluated with cognitive tests in the short, medium and long term in relation to the patient age and gender and the impact of retrograde perfusion and atherosclerotic burden [23].

Conclusion

Continuous field flooding insufflation of CO2 in MIMVR is associated with a lower incidence of micro-emboli, possibly due longer exposure to CO2, and a lower incidence of agitation at discontinuation of anesthesia as well as improved MV duration and ICU length of stay.

Declarations

Informed consent was obtained from all subjects involved in the study.

Conflict of interest

None.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Svenarud P, Persson M, van der Linden J. Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial. Circulation. 2004 Mar;9(9):1127–32.CrossRef Svenarud P, Persson M, van der Linden J. Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial. Circulation. 2004 Mar;9(9):1127–32.CrossRef
2.
Zurück zum Zitat Taylor RL, Borger MA, Weisel RD, et al. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg. 1999;68:89–93.CrossRefPubMed Taylor RL, Borger MA, Weisel RD, et al. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg. 1999;68:89–93.CrossRefPubMed
3.
Zurück zum Zitat Borger MA, Peniston CM, Weisel RD, et al. Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg. 2001;121:743–9.CrossRefPubMed Borger MA, Peniston CM, Weisel RD, et al. Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg. 2001;121:743–9.CrossRefPubMed
4.
Zurück zum Zitat Dalmas JP, Eker A, Girard C, et al. Intracardiac air clearing in valvular surgery guided by transesophageal echocardiography. J Heart Valve Dis. 1996;5:553–7.PubMed Dalmas JP, Eker A, Girard C, et al. Intracardiac air clearing in valvular surgery guided by transesophageal echocardiography. J Heart Valve Dis. 1996;5:553–7.PubMed
5.
Zurück zum Zitat van der Linden J, Casimir-Ahn H. When do cerebral emboli appear during open heart operations? A transcranial Doppler study. Ann Thorac Surg. 1991;51:237–41.CrossRefPubMed van der Linden J, Casimir-Ahn H. When do cerebral emboli appear during open heart operations? A transcranial Doppler study. Ann Thorac Surg. 1991;51:237–41.CrossRefPubMed
6.
Zurück zum Zitat Tingleff J, Joyce FS, Pettersson G. Intraoperative echocardiographic study of air embolism during cardiac operations. Ann Thorac Surg. 1995;60:673–7.CrossRefPubMed Tingleff J, Joyce FS, Pettersson G. Intraoperative echocardiographic study of air embolism during cardiac operations. Ann Thorac Surg. 1995;60:673–7.CrossRefPubMed
7.
10.
Zurück zum Zitat Eguchi S, Sakurai Y, Yamaguchi A. The use of carbon dioxide gas to prevent air embolism during open heart surgery. Acta Med Biol. 1963;11:1–13.PubMed Eguchi S, Sakurai Y, Yamaguchi A. The use of carbon dioxide gas to prevent air embolism during open heart surgery. Acta Med Biol. 1963;11:1–13.PubMed
11.
Zurück zum Zitat Speziale G, Santarpino G, Moscarelli M, Di Bari N, Fiore F, Condello I, Bartolomucci F, Bellino MC, Nasso G. Minimally invasive mitral valve reconstruction: Is it an “all-comers” procedure? J Card Surg. 2021 Nov 15. doi:https://doi.org/10.1111/jocs.16140. Speziale G, Santarpino G, Moscarelli M, Di Bari N, Fiore F, Condello I, Bartolomucci F, Bellino MC, Nasso G. Minimally invasive mitral valve reconstruction: Is it an “all-comers” procedure? J Card Surg. 2021 Nov 15. doi:https://​doi.​org/​10.​1111/​jocs.​16140.
12.
Zurück zum Zitat Spencer FC, Rossi NP, Yu SC, et al. The significance of air embolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1965;49:615–34.CrossRefPubMed Spencer FC, Rossi NP, Yu SC, et al. The significance of air embolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1965;49:615–34.CrossRefPubMed
13.
Zurück zum Zitat Eguchi S, Bosher LH Jr. Myocardial dysfunction resulting from coronary air embolism. Surgery. 1962;51:103–11.PubMed Eguchi S, Bosher LH Jr. Myocardial dysfunction resulting from coronary air embolism. Surgery. 1962;51:103–11.PubMed
15.
Zurück zum Zitat Martens S, Dietrich M, Wals S, et al. Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open heart surgery. Ann Thorac Surg. 2001;72:1940–4.CrossRefPubMed Martens S, Dietrich M, Wals S, et al. Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open heart surgery. Ann Thorac Surg. 2001;72:1940–4.CrossRefPubMed
16.
Zurück zum Zitat Persson M, van der Linden J. De-airing of a cardiothoracic wound cavity model with carbon dioxide: theory and comparison of a gas diffuser with conventional tubes. J Cardiothorac Vasc Anesth. 2003;17:329–35.CrossRefPubMed Persson M, van der Linden J. De-airing of a cardiothoracic wound cavity model with carbon dioxide: theory and comparison of a gas diffuser with conventional tubes. J Cardiothorac Vasc Anesth. 2003;17:329–35.CrossRefPubMed
17.
Zurück zum Zitat Persson M, Svenarud P, van der Linden J. Which is the optimal device for carbon dioxide de-airing of the cardiothoracic wound and how should it be positioned? J Cardiothorac Vasc Anesth. 2004;18:180–4.CrossRefPubMed Persson M, Svenarud P, van der Linden J. Which is the optimal device for carbon dioxide de-airing of the cardiothoracic wound and how should it be positioned? J Cardiothorac Vasc Anesth. 2004;18:180–4.CrossRefPubMed
18.
Zurück zum Zitat Salvatore Giordano F, Biancari. Does the use of carbon dioxide field flooding during heart valve surgery prevent postoperative cerebrovascular complications? Interact Cardiovasc Thorac Surg. 2009;9:323–6.CrossRefPubMed Salvatore Giordano F, Biancari. Does the use of carbon dioxide field flooding during heart valve surgery prevent postoperative cerebrovascular complications? Interact Cardiovasc Thorac Surg. 2009;9:323–6.CrossRefPubMed
19.
Zurück zum Zitat Webb WR, Harrison LH Jr, Helmcke FR, Camino-Lopez A, Munfakh NA, Heck Ha Jr, Mulder PV. Carbon dioxide field flooding minimizes residual intracardiac air after open-heart operations. Ann Thorac Surg. 1997;64:1489–91.CrossRefPubMed Webb WR, Harrison LH Jr, Helmcke FR, Camino-Lopez A, Munfakh NA, Heck Ha Jr, Mulder PV. Carbon dioxide field flooding minimizes residual intracardiac air after open-heart operations. Ann Thorac Surg. 1997;64:1489–91.CrossRefPubMed
20.
Zurück zum Zitat Martens S, Dietrich M, Wals S, Steffen S, Wimer-Greinecker G, Moritz A. Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open-heart surgery. Ann Thorac Surg. 2001;72:1940–4.CrossRefPubMed Martens S, Dietrich M, Wals S, Steffen S, Wimer-Greinecker G, Moritz A. Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open-heart surgery. Ann Thorac Surg. 2001;72:1940–4.CrossRefPubMed
21.
Zurück zum Zitat Kalpokas MV, Nixon IK, Kluger R, Beilby DS, Silbert BS. Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial. Perfusion. 2003;18:291–4.CrossRefPubMed Kalpokas MV, Nixon IK, Kluger R, Beilby DS, Silbert BS. Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial. Perfusion. 2003;18:291–4.CrossRefPubMed
22.
Zurück zum Zitat Skidmore KL, Jones C, DeWet C. Flooding the surgical field with carbon dioxide during open-heart surgery improves segmental wall motion. J Extra Corpor Technol. 2006;38:123–7.PubMedPubMedCentral Skidmore KL, Jones C, DeWet C. Flooding the surgical field with carbon dioxide during open-heart surgery improves segmental wall motion. J Extra Corpor Technol. 2006;38:123–7.PubMedPubMedCentral
23.
Zurück zum Zitat Wang H, Guo X, Zhu X, Li Y, Jia Y, Zhang Z, Yuan S, Yan F. Gender differences and postoperative delirium in adult patients undergoing cardiac valve surgery. Front Cardiovasc Med. 2021;8:751421.CrossRefPubMedPubMedCentral Wang H, Guo X, Zhu X, Li Y, Jia Y, Zhang Z, Yuan S, Yan F. Gender differences and postoperative delirium in adult patients undergoing cardiac valve surgery. Front Cardiovasc Med. 2021;8:751421.CrossRefPubMedPubMedCentral
Metadaten
Titel
Continuous field flooding versus final one-shot CO2 insufflation in minimally invasive mitral valve repair
verfasst von
Giuseppe Nasso
Ignazio Condello
Giuseppe Santarpino
Nicola Di Bari
Marco Moscarelli
Felice Eugenio Agrò
Roberto Lorusso
Giuseppe Speziale
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2022
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-022-02020-4

Weitere Artikel der Ausgabe 1/2022

Journal of Cardiothoracic Surgery 1/2022 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.